Ensign Peak Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-168,180
| Closed | -$11.5M | – | 2339 |
|
|
2022
Q3 | $11.5M | Buy |
168,180
+75,416
| +81% | +$5.14M | 0.03% | 355 |
|
|
2022
Q2 | $2.96M | Buy |
92,764
+74,654
| +412% | +$2.39M | 0.01% | 671 |
|
|
2022
Q1 | $627K | Sell |
18,110
-55,542
| -75% | -$1.92M | ﹤0.01% | 1455 |
|
|
2021
Q4 | $2.16M | Buy |
73,652
+73,552
| +73,552% | +$2.15M | ﹤0.01% | 927 |
|
|
2021
Q3 | $3K | Sell |
100
-62,689
| -100% | -$1.88M | ﹤0.01% | 1850 |
|
|
2021
Q2 | $2.2M | Buy |
62,789
+32,100
| +105% | +$1.12M | ﹤0.01% | 1077 |
|
|
2021
Q1 | $1.25M | Sell |
30,689
-108,569
| -78% | -$4.43M | ﹤0.01% | 1336 |
|
|
2020
Q4 | $6.03M | Buy |
139,258
+20,458
| +17% | +$886K | 0.01% | 551 |
|
|
2020
Q3 | $6.55M | Buy |
118,800
+29,180
| +33% | +$1.61M | 0.02% | 544 |
|
|
2020
Q2 | $5.66M | Buy |
89,620
+24,570
| +38% | +$1.55M | 0.02% | 582 |
|
|
2020
Q1 | $3.32M | Buy |
65,050
+36,288
| +126% | +$1.85M | 0.01% | 628 |
|
|
2019
Q4 | $2.29M | Buy |
+28,762
| New | +$2.29M | 0.01% | 997 |
|